<DOC>
	<DOC>NCT00000303</DOC>
	<brief_summary>The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, baclofen is tested.</brief_summary>
	<brief_title>Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6</brief_title>
	<detailed_description>16-week participation plus a 2 week lead in period. Participants are assigned randomly to placebo or baclofen. Participant attend group meetings 3 x/week.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>M/F ages 1865. cocaine dependence according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSMIV) criteria. Selfreported use within the last 30 days. Agreeable to conditions of study and signed informed consent. Psychiatric disorder that requires medication therapy, history of seizures, pregnant and/or nursing women, dependence on ethanol (ETOH) or benzodiazepines or other sedativehypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cocaine dependence</keyword>
</DOC>